Viewing Study NCT03491904


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2026-05-14 @ 9:21 PM
Study NCT ID: NCT03491904
Status: COMPLETED
Last Update Posted: 2021-03-03
First Post: 2018-04-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Assess the Patients' Ability to Self-Administer Fasinumab
Sponsor: Regeneron Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Osteoarthritis, Knee View
None Osteoarthritis, Hip View
Keywords: